| 0 (0%) | 10-20 20:01 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 31.22 | 1-year : | 37.42 |
| Resists | First : | 26.73 | Second : | 32.04 |
| Pivot price | 20.1  |
|||
| Supports | First : | 18.15 | Second : | 15.1 |
| MAs | MA(5) : | 19.47  |
MA(20) : | 21.46 |
| MA(100) : | 26.08 |
MA(250) : | 19.63 |
|
| MACD | MACD : | -2.5 |
Signal : | -2.8 |
| %K %D | K(14,3) : | 20 |
D(3) : | 15.4 |
| RSI | RSI(14): 39.9 |
|||
| 52-week | High : | 44.27 | Low : | 9.05 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ YARW ] has closed below upper band by 48.3%. Bollinger Bands are 36.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 20.52 - 20.59 | 20.59 - 20.65 |
| Low: | 19.42 - 19.51 | 19.51 - 19.59 |
| Close: | 20.07 - 20.21 | 20.21 - 20.33 |
Mon, 19 Oct 2026
The Technical Signals Behind (YARW) That Institutions Follow - Stock Traders Daily
Thu, 15 Oct 2026
Bellevue reports 10.6 percent stake in Yarrow Bioscience stock - ad-hoc-news.de
Wed, 07 Oct 2026
A passive investor reports ownership of 1 million Yarrow Bioscience (YARW) shares. - Stock Titan
Thu, 10 Sep 2026
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering - Business Wire
Thu, 30 Jul 2026
Yarrow Bioscience Inc (YARW) stock price, news, quote and history - Yahoo Finance UK
Wed, 29 Jul 2026
What is the current Price Target and Forecast for Yarrow Bioscience, Inc (YARW) - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 9 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 38.2 (%) |
| Shares Short | 190 (K) |
| Shares Short P.Month | 57 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 335.63 |
| Dividend | 20.1 |
| Forward Dividend | 0 |
| Dividend Yield | 99.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|